Poland - Blood test reagents

For more information and to make a bid you will need to go to the third party website.

Details

Provided by Open Opps
Opportunity closing date
22 January 2020
Opportunity publication date
16 December 2019
Category
33696200: Blood-testing reagents
Value of contract
to be confirmed
Your guide to exporting
Report opportunity

Description

Test for identification of respiratory viruses (influenza A and B, paragraphs 1, 2, 3, adenoviruses and RS viruses).Test for identification of HSV 1 and HSV 2 directly in the patient material.Test for detection and identification of chlmaydophila pneumoniae directly in the patient material. Ig G antiplatelet heparin antibody detection assay by immunoenzymatic method (ELISA), positive and negative control plus single stripes-straps packed separately - 225 tests. Tests and kits - 15 items described in detail in the specification. A marker for marking preparations on a hydrophobic base slide, which allows the liquid (reagent) to be maintained in the contoured area. Test for the determination of early pp65 CMV antigen in leukocytes isolated from peripheral blood by indirect immunofluorescence: the test contains reagents for the isolation of leukocytes from peripheral blood, fixative, membrane permabilising reagent, and a set of antibodies: antibody directed against CMV antigen pp65 and secondary antibody conjugated with FITC. Direct immunofluorescence (DFA) test for the identification of pneumocystis carinii cysts directly in the patient material: The test contains a pneumocystis carinii antigen antibody conjugated to FITC. Solutions, liquids, mixtures - 16 items described in the specification. Screening and marking test - 15 items described in detail in the specification. Test to identify the legionella pneumophila antigen directly in the material tested by direct fluorescence, 1 pack is sufficient for approximately 24 tests, and the kit also includes positive control. Streptavidine: FITC-reagent for the identification of biotinylated antibody; rabbit polyclonal anti-mycoplasma pneumoniae antibody.

Opportunity closing date
22 January 2020
Value of contract
to be confirmed

About the buyer

Address
Śląskie Centrum Chorób Serca w Zabrzu ul. M. C. Skłodowskiej 9 Zabrze 41-800 Poland
Contact
przetargi@sccs.pl

The deadline to apply for this opportunity has passed.
Visit the opportunities page to find another.

Is there anything wrong with this page?